AxoGen reported earnings of $ 0.21 per AXGN share on Oct 28, 2026, beating analysts' expectations by
| Report Date | Oct 28, 2026 |
|---|---|
| Forecasted EPS | $ 0.1313 |
| Earnings Per Share (Surprise) | $ 0.21 (+$ 0.0787) |
| Last Year's EPS | $ 0.0725 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, AxoGen beat analysts’ expectations 37 times and fell short of expectations 18 time(s). AxoGen reported earnings per share of $ 0.21 in the last report surpassing an estimated EPS of $ 0.1313 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 28, 2026 | $ 0.1313 | $ 0.21 | $ 0.12 | |
| Jul 29, 2026 | $ 0.1214 | $ 0.12 | $ 0.12 | |
| Apr 28, 2026 | $ 0.12 | $ 0.07 | -$ 0.02 | |
| Feb 24, 2026 | $ 0.08879 | $ 0.07 | $ 0.08 | |
| Oct 29, 2025 | $ 0.09 | $ 0.12 | $ 0.07 | |
| Aug 5, 2025 | $ 0.06 | $ 0.12 | $ 0.05 | |
| May 8, 2025 | -$ 0.01 | -$ 0.02 | -$ 0.06 | |
| Feb 25, 2025 | $ 0.04 | $ 0.08 | -$ 0.06 | |
| Nov 7, 2024 | $ 0.006 | $ 0.07 | $ 0.01 | |
| Aug 8, 2024 | -$ 0.05 | $ 0.05 | -$ 0.03 | |
| May 2, 2024 | -$ 0.10 | -$ 0.06 | -$ 0.10 | |
| Mar 5, 2024 | -$ 0.09 | -$ 0.06 | -$ 0.03 | |
| Nov 7, 2023 | -$ 0.08 | $ 0.01 | -$ 0.01 | |
| Aug 7, 2023 | -$ 0.15 | -$ 0.03 | -$ 0.06 | |
| May 9, 2023 | -$ 0.15 | -$ 0.10 | -$ 0.20 | |
| Mar 14, 2023 | -$ 0.10 | -$ 0.03 | -$ 0.08 | |
| Nov 8, 2022 | -$ 0.15 | -$ 0.01 | -$ 0.09 | |
| Aug 3, 2022 | -$ 0.15 | -$ 0.06 | -$ 0.09 | |
| May 4, 2022 | -$ 0.17 | -$ 0.20 | -$ 0.08 | |
| Feb 22, 2022 | -$ 0.13 | -$ 0.08 | -$ 0.08 |
AxoGen’s stock was trading at $ 37.46 on Oct 27, 2026 a day before the last earnings report was released.Following the release of the earnings report, AXGN’s price increased to $ 49.63 on Oct 29, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 28, 2026 | $ 0.21 | $ 37.46 | $ 49.63 | |
| Jul 29, 2026 | $ 0.12 | $ 41.15 | $ 41.35 | |
| Apr 28, 2026 | $ 0.07 | $ 39.39 | $ 41.77 | |
| Feb 24, 2026 | $ 0.07 | $ 35.38 | $ 31.22 | |
| Oct 29, 2025 | $ 0.12 | $ 18.08 | $ 22.68 | |
| Aug 5, 2025 | $ 0.12 | $ 12.55 | $ 13.75 | |
| May 8, 2025 | -$ 0.02 | $ 16.39 | $ 11.37 | |
| Feb 25, 2025 | $ 0.08 | $ 18.01 | $ 19.46 | |
| Nov 7, 2024 | $ 0.07 | $ 15.33 | $ 12.66 | |
| Aug 8, 2024 | $ 0.05 | $ 7.92 | $ 11.02 | |
| May 2, 2024 | -$ 0.06 | $ 6.56 | $ 5.79 | |
| Mar 5, 2024 | -$ 0.06 | $ 10.59 | $ 9.06 | |
| Nov 7, 2023 | $ 0.01 | $ 3.93 | $ 5.40 | |
| Aug 7, 2023 | -$ 0.03 | $ 8.42 | $ 6.67 | |
| May 9, 2023 | -$ 0.10 | $ 9.66 | $ 9.49 | |
| Mar 14, 2023 | -$ 0.03 | $ 7.53 | $ 8.40 | |
| Nov 8, 2022 | -$ 0.01 | $ 10.68 | $ 12.71 | |
| Aug 3, 2022 | -$ 0.06 | $ 10.27 | $ 10.49 | |
| May 4, 2022 | -$ 0.20 | $ 7.92 | $ 9.77 | |
| Feb 22, 2022 | -$ 0.08 | $ 7.39 | $ 7.98 |
AxoGen released its most recent earnings reports in October 2026, July 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
AxoGen beat analysts’ expectations during the last earnings period by
